医药分开的政策导向早已从顶端设计自上而下贯通,并在医改实践中被不断分解为细则和行动,但为何迟迟收不到应有的效果,问题的落脚点最终回到“利益”二字。一位投资界的人士日前打来电话与记者进行交流,与以往不同的是,他的兴趣点由恒定不变的医药电商突然跳跃到实体药店。对此,他的解释是:第一,以天猫医药馆、1号店和八百方为代表的第三方药品交易平台因为试点到期,陆续宣布停止药品B2C业务,这使得一度被互联网挤压变形的实体药品零售有了缓冲的时间和空间,在走出概念化而实现场景化的O2O的催化下,或将 The policy guidance for the separation of medicine has long been top-down through top-level design and has been continuously broken down into rules and actions in the practice of medical reform. However, why the delay has not been achieved and the ultimate goal of the problem has finally come back to the “interests ”Word. An investment community recently called and journalists to communicate with the past, different from the past, his point of interest by the immutable medical e-commerce suddenly jumped to the entity pharmacy. In this regard, his explanation is as follows: First, the third-party drug trading platform represented by Tmall Pharmacy, No. 1 Pharmacy and Yao Baifang has successively announced the cessation of the pharmaceutical B2C business due to the trial expiration, Pressure-deformable physical pharmacy retailers have the time and space to buffer, out of the conceptualization of the scene to achieve the catalytic O2O or